Clinical Trials Directory

Trials / Unknown

UnknownNCT06214494

Blood Flow Restricted High-Intensity Treadmill Training on Independently Ambulating Chronic Ischemic CVA Survivors

Effects of Blood Flow Restricted High Intensity Treadmill Training on Independently Ambulating Chronic Ischemic CVA Survivors: A Pilot Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
MedStar National Rehabilitation Network · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Individuals surviving Chronic Ischemic Stroke have lingering walking deficits long after their infarct. The main goal of this study is to compare two high intensity treadmill walking programs to see which improves walking more. The main question we aim to answer is: How does blood flow restricted high-intensity treadmill training impact walking function? Participants will be randomly separated into two groups. One group will perform the high intensity treadmill training with blood flow restriction on their Stroke affected leg, while the second group performs high intensity treadmill training only. Every week participants will be asked to walk on the treadmill for a total of 75 minutes during 2x 1-hour sessions. On visit 1, participants will undergo strength, balance, and walking testing. They will then be treated 2x weekly for 4 weeks (visit 2-9) and be re-tested to track progress on visit 10. Participants will again be treated 2x weekly for 4 more weeks (visit 11-18) and be tested to see the end results on visit 19. Researchers will then compare both groups to see if blood flow restriction training changes walking function, strength, and balance.

Conditions

Interventions

TypeNameDescription
OTHERBlood Flow Restricted High Intensity Treadmill TrainingBlood Flow Restricted High Intensity Treadmill Training at 70% limb occlusion (on hemiparetic limb only) 2x weekly for 16 Sessions totaling minimum of 75 minutes weekly.
OTHERHITTHigh Intensity Treadmill Training 2x weekly for 16 Sessions totaling minimum of 75minutes weekly.

Timeline

Start date
2024-03-01
Primary completion
2024-07-31
Completion
2024-08-01
First posted
2024-01-19
Last updated
2024-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06214494. Inclusion in this directory is not an endorsement.